Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
What is value investing? Discover the principles behind this strategy and how it can enhance your investment approach.
19,897 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Kharg Island, a key Iran oil export hub, is under the spotlight as geopolitical tensions heighten risk to energy flow...
When markets wobble, investors ask a familiar question: should sell your stocks? History shows a simple rule: avoid p...
Wheat futures jumped about 15% in a month, signaling inflation pressures and prompting investors to consider hedges. ...
A high-stakes clash over FCC rules has echoes for your wallet. This article breaks down how regulatory battles around...
When Palantir reveals new AI-focused capabilities, Nvidia stock often faces a unique set of pressures. This guide bre...
The United States and Europe are pursuing different routes to regulate AI, and the early market impact is clear—from ...
A famous endorsement pulled ordinary investors into a wild crypto ride, ending in legal battles and hard lessons. Thi...
Bitcoin jumped to an intraday high near $82,000 on Thursday after a Senate committee advanced the Clarity Act, then e...
Microsoft’s AI chief predicts broad automation of office work within 18 months, a forecast senior economists say coul...
A sweeping policy update relaxes 401(k) limits, allowing alternative assets in workplace plans. The change comes afte...
A new 2026 survey shows Gen Z is leaning into financial independence, saying ‘no’ more often to costly experiences an...